Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Mounjaro

Tirzepatide

Open in the dashboard

Part D claims

4,694,896

Prescriptions dispensed, refills included

Drug cost

$5,825,295,741

Paid at the pharmacy, in all

Prescribers

97,208

With 11 or more claims of it

In 2024, Medicare Part D recorded 4,694,896 claims for Mounjaro (tirzepatide) from 97,208 prescribers, at a total drug cost of $5.8 billion paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 56 states and territories
Part D claims for Mounjaro by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
TX 8,990 460,092 $583,005,531
FL 7,362 365,714 $457,562,722
NY 5,098 276,824 $354,054,412
CA 5,616 251,231 $299,229,889
GA 3,613 209,307 $260,207,571
MI 4,048 191,815 $237,532,714
NC 3,928 174,952 $214,699,879
LA 2,389 173,261 $210,066,015
PA 3,962 173,061 $212,894,895
AL 2,337 169,572 $205,328,587
OH 3,748 162,690 $200,731,646
TN 2,982 154,961 $189,391,308
IN 2,811 154,332 $197,510,866
IL 3,091 128,330 $159,586,043
SC 2,194 117,773 $149,599,862
The other 41 states and territories
State Prescribers Claims Drug cost
KY 2,224 116,743 $136,024,358
NJ 2,235 113,770 $148,014,703
MO 2,334 112,305 $136,907,143
OK 1,779 92,310 $113,374,790
MA 1,771 81,673 $100,060,941
VA 1,833 71,821 $89,943,026
AR 1,350 69,881 $81,539,618
AZ 1,762 66,538 $85,767,085
MS 1,142 60,427 $75,468,539
WI 1,570 58,978 $72,043,088
CT 1,062 56,065 $72,856,562
MD 1,296 55,384 $75,281,920
CO 1,296 49,215 $63,335,484
WV 971 48,258 $62,917,894
WA 1,363 47,674 $59,872,456
KS 1,129 47,552 $55,457,123
IA 1,061 42,611 $49,232,201
MN 1,241 39,594 $48,189,728
NV 811 39,191 $51,516,951
UT 891 37,632 $45,889,352
NE 707 28,129 $31,904,450
ID 633 26,339 $30,508,344
OR 751 23,257 $28,344,944
NM 543 20,190 $25,169,054
NH 378 16,518 $20,601,494
PR 262 14,939 $16,973,372
ME 434 14,918 $17,916,286
SD 314 13,780 $15,903,136
DE 315 12,129 $16,522,780
HI 243 8,490 $12,931,109
ND 247 8,467 $9,492,016
MT 264 7,958 $9,482,007
RI 204 6,462 $7,368,471
AK 160 5,829 $7,490,752
WY 174 5,655 $6,391,323
DC 120 5,090 $6,996,920
VT 153 4,498 $5,252,575
AP 4 352 $478,840
VI 9 314 $410,807
XX 2 33 $48,584
ZZ 1 12 $13,573

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 15 of 78
Part D claims for Mounjaro by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Family Practice 31,352 1,299,946 $1,577,818,050
Internal Medicine 22,950 1,117,261 $1,368,546,393
Nurse Practitioner 24,158 1,038,246 $1,281,773,396
Endocrinology 5,230 694,945 $936,724,648
Physician Assistant 8,190 333,034 $409,744,056
Cardiology 884 42,684 $50,505,040
General Practice 900 36,509 $43,503,688
Nephrology 357 17,494 $21,127,924
Pharmacist 356 16,266 $19,244,905
Emergency Medicine 277 11,399 $13,474,430
Hospitalist 267 9,529 $11,339,523
Pediatric Medicine 209 7,701 $9,336,530
Geriatric Medicine 225 7,590 $8,944,518
General Surgery 190 6,664 $7,602,572
Certified Clinical Nurse Specialist 79 6,471 $8,434,970

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Eugenio Angueira-Serrano Endocrinology FL 1,949 $2,120,125 $183
Gary Reznik Cardiology CA 1,751 $1,838,391 $60
Stella Ilyayeva Internal Medicine NY 1,720 $2,022,249 None on record
Shahed Quyyumi Endocrinology NY 1,709 $2,467,776 $161
Iraklii Buziashvili Endocrinology NY 1,704 $1,845,115 $22

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

Other names for tirzepatide

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record